Healthcare -
Biotechnology - NASDAQ - US
$ 3.6
2.86 %
$ 308 M
Market Cap
-0.94
P/E
AMLX - REVENUE
Revenue AMLX - Amylyx Pharmaceuticals, Inc.
381 M
LAST VALUE
3555.26%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR